PartnerCapital Markets & M&A · promerget GmbH
Aladar Tepelea
Aladar began his career in Corporate Finance at Novartis, where he was involved in the USD 5.4 billion sale of the Animal Health division to Eli Lilly. At BlackRock, he focused on strategic M&A, FinTech innovation and business development. As interim CFO of Proxeus, he co-led a USD 25 million funding round. Since then, as founder, advisor, investor and board member, he has supported several seed and Series A financing rounds of his own and third-party ventures.
- Fundraising · Seed to Series A
- Strategic M&A
- FinTech
- Investor access
- NovartisCorporate Finance. Divestment of the Animal Health division to Eli Lilly.
- BlackRockBusiness Manager. Strategic M&A, FinTech innovation, business development.
- ProxeusInterim CFO. Swiss blockchain venture; co-led a USD 25M funding round.
- VenturesFounder, advisor, investor and board member. Seed and Series A rounds for own and third-party ventures.